ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

Possible Association Between Agent Orange, AML, IOM Says.

April 27, 2001

UICC Fellowship Program Announced

January 2, 1981

Steven Woolf: Why CMS Should Not Cover LDCT

May 9, 2014

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

July 4, 2003

NCI Plans Research To Reduce Cancer Disparities.

June 16, 2000

Upton Tells Press He Wasn’t Hired To Push Prevention

August 5, 1977